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ABSTRACT 
 
Objectives 
Childhood cancer poses a significant public health burden, both globally and in the 
United States (US). The most common childhood cancers affect the brain and central 
nervous system (CNS). Age-adjusted childhood brain tumor (CBT) incidence rates in 
Kentucky are larger than in the rest of the US; these rates are also higher in Appalachian 
Kentucky than in the rest of the state. This study determined if high-rate clusters of either 
CNS tumor or retinoblastoma existed in Kentucky. 
 
Methods 
Data for this study were retrieved from the Kentucky Cancer Registry for the years 1995 
through 2014. Cases were individuals between the ages of 0 and 19 years that were 
diagnosed with either retinoblastoma (N=81) or a CNS tumor (N=1042). Population data 
for demographic subgroups defined by binary combinations of age, sex, and race were 
obtained from the CDC WONDER Bridged-Population database. Spatial scan statistics, 
used to identify high-rate clusters of CBT, were implemented using SaTScan Version 
9.4.4. Clusters were mapped using ArcGIS version 10.4.1. 
 
Results 
One significant high-rate cluster of CNS tumor cases was identified across the northern 
part of Appalachian Kentucky and northern and central parts of Kentucky (p<0.0001), but 
there were no significant high-rate clusters of retinoblastoma cases. 
 
Conclusions 
The significant cluster identified by the spatial scan statistic somewhat corresponds to 
previous findings indicating a higher rate of these cancers in the Appalachian region, but 
it was not confined to Appalachia. Future aims of this pilot study are to identify possible 
risk factors that may be causing this increase.  
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INTRODUCTION 
Childhood cancer poses a significant global public health burden, with between 
175,000 and 250,000 incident cases annually.1 While approximately 90% of childhood 
cancer cases occur in developing countries, the American Cancer Society (ACS) 
estimates that, in 2017, 10,270 incident cases of cancer will be diagnosed among 
children, aged 14 years and under, in the United States (U.S.), where incidence rates for 
childhood cancers have increased annually by 0.6% since 1975.1,2 Although mortality 
rates have decreased from 6.5 to 2.0 (per 100,000 persons) between 1969 and 2014, it is 
estimated that 1,190 deaths from childhood cancer will occur in 2017; the US relative 
survival rate for all childhood cancers is 83%.2 
The most common solid tumors that affect children occur in the brain and central 
nervous system (CNS) (26% of all childhood cancers), with a  five-year survival rate of 
79%.2 The histological subtypes of childhood brain tumors (CBTs) include gliomas 
(which arise from glial cells) and tumors of embryonic cells (which develop if these cells 
are present in the CNS post-partum).3-5 The most common CBT in children, aged 14 
years and under, is pilocytic astrocytoma, which comprises 17% of all CNS tumors in 
children; incidence rates are between 0.74 to 0.9 (per 100,000 persons), with a 10-year 
survival rate greater than 96%.3,6 Retinoblastoma comprises 2% of all cancers diagnosed 
in children under age 5 years and has a five-year survival rate of 95%.7 Less common 
forms of CBT include brain stem glioma, diffuse astrocytoma, high-grade astrocytoma, 
primitive neuroectodermal tumor (PNET), medulloblastoma, and atypical 
teratoid/rhabdoid tumor (ATRT).3,5  
University of Kentucky  Khoury | 3 
There are currently few recognized risk factors for CBTs, including ionizing 
radiation exposure and certain cancer syndromes, though there have been several studies 
where researchers examined other potential risk factors3,8-30 These include advanced 
parental age, parental exposures (i.e., maternal nutrition, cigarette smoking, proximity to 
radiofrequency electromagnetic fields, paternal occupational exposure to radiation or 
chemicals), high socioeconomic status, birth defects, markers of fetal growth, genotype 
interactions, residential pesticide exposure, and certain infections. 
Previously, researchers conducted a study comparing pediatric brain tumor 
incidence in Appalachian versus non-Appalachian regions to determine if astrocytoma 
risk among Appalachian children was greater than national rates. From the North 
American Association of Central Cancer Registries (NAACR), for the years 2001 
through 2011, Huang, et. al., identified CNS tumor cases, diagnosed in approximately 
27,000 non-Appalachian and 2,200 Appalachian individuals between the ages of 0 and 
19. Here, researchers determined that pediatric CNS tumor incidence rates (reported per 
100,000 with 95% confidence intervals (CIs)) were greater among Appalachian (3.31, 
3.17-3.45) cases than among non-Appalachian cases (3.06,3.02-3.09). Additionally, from 
the years 2004 through 2011, researchers determined that World Health Organization 
(WHO) grade I astrocytomas were greater in Appalachia (0.63, 0.56-0.70) than in non-
Appalachia (0.44, 0.43-0.46).31  
Presenters to the Interim Joint Committee on Health and Welfare (September 21, 
2016) observed that age-adjusted childhood cancer incidence rates, from 1999 through 
2013 (per 1,000,000), when compared to the entire state of Kentucky and to the U.S., are 
larger in Appalachian Kentucky; that is, 184.0 compared to 176.0 and 174.0 in Kentucky 
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and in the U.S.32 These differences were statistically significant (p<0.05) among males 
(age-adjusted incidence of 202.0 per 1,000,000 compared to 188.0 for the entire state and 
182.0 for the U.S.). Incidence rates for CNS cancers were also significantly higher when 
comparing Appalachian Kentucky to the U.S. (approximately 40.0 per 1,000,000 versus 
approximately 32.0 per 1,000,000).  
Table 1.1 shows age-adjusted incidence rates (per 1,000,000) and 95% confidence 
intervals (CIs) for pediatric CNS tumors and retinoblastoma for individuals between ages 
0 and 19 years from 2010 through 2014.33,34 Rates are shown for Appalachian Kentucky, 
the whole state of Kentucky, and the U.S.; these are considered significantly different 
from each other since CIs do not overlap. During this time period, incidence rates of CNS 
tumor were significantly greater in Appalachian Kentucky (45.7, 35.4-58.0) and the 
whole state of Kentucky (40.5, 35.4-46.1) than in the U.S. (32.2, 31.6-32.7). The 
incidence rate for retinoblastoma cases in Appalachian Kentucky during this period was 
not stable from 2010 to 2014 because the case count was less than 15; this is marked in 
the table with an asterisk. There were no statistically significant differences when 
comparing incidence rates for retinoblastoma. 
To investigate this phenomenon, the present study focused on identifying regions 
of Kentucky where clusters of CBTs exist. CBTs of interest for this study include CNS 
cancers defined by site groupings specified by the International Classification of 
Childhood Cancer (ICCC). These site groupings are based on the International 
Classification of Diseases for Oncology (ICD-O-3) and the World Health Organization 
(WHO) Classification of Tumors of Haemotopoietic and Lymphoid Tissues (2008) (ICD-
O-3/WHO 2008); groupings are based on site and histology combinations. Cancer groups 
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for this project include “III CNS and miscellaneous intracranial and intraspinal 
neoplasms” and “V Retinoblastoma”.35 Throughout this paper, these defined cancer 
groups will be referred to as CNS tumor and retinoblastoma. 
The results of this study will be used to guide further research into this topic, 
including later identifying possible risk factors that may be associated with increased risk 
of either CNS tumor or retinoblastoma within significant clusters. After determining risk 
factors within clusters, these results can be used to target interventions and reduce 
pediatric CNS tumors and/or retinoblastoma in high-rate areas. 
LITERATURE REVIEW 
 A literature review was completed using PubMed, an online database containing 
peer-reviewed publications that pertain to life and biomedical sciences; this is maintained 
by the United States National Library of Medicine at the National Institutes of Health. 
The following keyword searches were performed to identify pertinent resources: 
“childhood brain tumors”, “childhood astrocytoma risk”, and “childhood CNS tumors 
risk”. Results were restricted to those publications that were published within the past 10 
years and studied human subjects.  
Prenatal Factors/Parental Exposures 
 Several researchers have assessed the relationship between CBTs and prenatal 
risk factors, including environmental exposures among parents (i.e., maternal nutrition, 
parental smoking, and parental environmental exposures).  
These studies show that dietary factors and nutritional supplements may have a 
protective effect against CBTs. In an international case-control study looking at cases 
diagnosed between 1982 and 1992 Pogoda, et. al., revealed that maternal consumption of 
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cruciferous vegetables and fresh fish significantly reduced the risk of anaplastic 
astrocytoma and astroglial tumor.29 Milne, et. al. (2012), in an Australian case-control 
study conducted between 2005 and 2011, showed that mothers who used folic acid 
supplements prior to pregnancy had children with the lowest risk of CBT; risk was also 
lower among children of mothers that used supplements during pregnancy.22 A different 
study identified a possible negative association between pre-pregnancy folic acid 
supplementation and CBT risk where a mother, father, or child has the MTRR 66GG 
genotype; this genotype alone, however, does not significantly decrease the risk when it 
is present in a child or father.30 Conversely, Mortensen, et. al., who conducted a 
population-based cohort study in Norway reported that there was not an association 
between maternal supplemental folic acid use and CBT tumor risk in their offspring.25 
 Published literature indicates that there are no significant associations between 
CBT risk and parental smoking either during or prior to pregnancy. Huang, et. al., 
performed a meta-analysis and found that relative risks were not greater for children of 
either mothers or fathers that smoked; results were consistent when assessing if risk 
increased with dose of cigarette smoke.19 Milne, et. al. (2013), in an Australian 
population-based case-control study reported similar results, with no significant ORs for 
any parental smoking.23 Barrington-Trimis, et. al., in a case-control study examining 
polymorphism genotypes using neonatal dried blood spots, found that high-risk genotype 
EPHX1 H139R increased risk of CBT, with an additional dose-response pattern for 
paternal smoking; these results, however, were not statistically significant.9 
 Multiple researchers have conducted case-control studies to assess other parental 
exposures. Assessing maternal exposure to mobile phone base stations during pregnancy, 
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Elliott, et. al., reported no significant associations to CBT risk.16 Keegan, et. al., 
considered paternal occupation and social class, as derived from fathers’ occupations at 
the time of their child’s birth, and observed significantly increased CNS tumor risk for 
children with fathers exposed to farm animals (OR=1.40, 95% CI 1.01-1.94) and to lead 
(OR=1.18, 95% CI 1.01-1.39). Increased risk associated with exposure to farm animals 
may be related to pesticide exposure, and the effect of lead was only significant after 
adjusting for social class.21 In a study of parental occupational solvent exposure, Peters, 
et. al., reported a significantly increased risk for children with fathers who were exposed 
to aromatic solvents other than benzene (OR=1.76, 1.10-2.82).28  
Perinatal Risk Factors 
 Several researchers have conducted studies to determine if associations exist 
between the development of CBTs and several perinatal risk factors (i.e., fetal growth, 
maternal/familial history, maternal infections, and birth defects).  
High fetal growth is a term used to describe the development of infants who are 
large for gestational age (LGA).14 An infant that is LGA has a birthweight that is greater 
than the 90th percentile for their gestational age. LGA can occur for multiple reasons, 
including genetic factors, a mother gaining excessive weight during pregnancy, and 
maternal diabetes. Many of the problems associated with LGA children include increased 
incidence of birth defects, low blood sugar (LBS or hypoglycemia) after delivery, and 
respiratory distress.36   
Multiple researchers have recognized that there is an association between high 
fetal growth and an increased risk for CBTs.10,14,27 O’Neill, et. al., in a population-based 
case-control with study data from the U.S. and the United Kingdom (U.K.), observed 
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high birth weight was associated with an increased risk of CNS tumors in both datasets, 
reported as odds ratios (ORs) with 95% CIs (U.S. OR=1.10, 1.06-1.13; U.K. OR=1.07, 
1.04-1.10).27 Crump, et. al., in a Swedish cohort study that followed subjects born 
between 1973 and 2008, observed that subjects with high fetal growth had significantly 
increased risk, independent of gestational age; results here suggest that growth factor 
pathways may be important to the etiology of certain brain tumors.14 Bhatti, et. al., in a 
Washington state case-control study testing for circulating vitamin D3 levels from 
neonatal blood spots in birth records, observed that children with higher birth weights had 
greater vitamin D3 levels in their blood and were at greater risk of developing CBT; ORs, 
presented with 95% CIs, comparing higher to lower birth weight children in quartiles of 
vitamin D3 levels (2nd=1.7, 1.0-3.3; 3rd=2.4, 1.2-4.8; 4th=2.6; 1.2-5.6).10 Since vitamin D3 
concentrations are affected by insulin-like growth factor 1 (IGF-1), this may be a growth 
factor pathway influencing the results of the above Swedish study.10 Milne, et. al. (2008), 
who conducted a Western Australian population-based cohort study using intra-uterine 
growth measures rather than birth weight, however, observed that there was little 
evidence that fetal growth was associated with CNS tumor development.24  
Researchers have also examined the relationship between maternal and familial 
history.11,14 Cantwell, et. al., in a Northern Ireland population-based cohort study that 
following persons born between 1971 and 1986, found that the risk of CBT was 
significantly greater among children born into larger families or to mothers with an 
obstetric history of miscarriage, reported with a 95% CI (OR=1.68, 1.16-2.42).11 In the 
previously mentioned Swedish study, Milne, et. al., (2008), observed that risk of CBT 
was greatest among those with a first degree history of brain tumor and those born to 
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mothers with high educational achievement.14 This may relate to the findings of a 
California study that reported risk of glioma increased with maternal age over 35 years 
(OR=1.87, 1.00-3.52).26 In a U.S. population-based case-control study of data pooled 
from five states, Carozza, et. al., reported a similar association, recognizing that ORs for 
astrocytoma were reduced by 30 to 40% for lower parental education levels.12 Johnson, 
et. al., in a similar multi-state study, observed a significant increase in childhood CNS 
tumors, with positive linear trends per five-year maternal age increase (OR=1.07, 1.03-
1.10).20 
Related studies have been conducted to assess the relationship between maternal 
infections, childhood birth defects, and CBT risk in California. In a case-control study of 
children under age 16 years diagnosed with CNS tumors between 1988 and 2008, 
Oksuzyan, et. al., found that mothers with genital herpes or blood/immune disorders 
during pregnancy had children with significantly greater risk of CNS tumors 
(respectively, 2.74, 1.16-6.51; and 2.28, 1.08-4.83). Researchers also observed a 
protective effect for mothers with non-sexually transmitted infections (STIs) during 
pregnancy (0.28, 0.09-0.85).26 Fisher, et. al., in a population-based cohort study of 
children born between 1988 and 2004, recognized that childhood cancer risk is greater in 
children with chromosomal birth defects, reported as hazard ratio (HR) with a 95% CI 
(HR=12.44, 10.10-15.32); risk was also greater with non-chromosomal birth defects, 
especially for brain and other solid tumors (1.58, 1.33-1.87).17 
Childhood Exposures 
 Fewer researchers have assessed the role of childhood exposures. Dobbins, et. al., 
in a case-control study considering the influence of genotype on asthma and glioma risk 
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found that the single nucleotide polymorphism (SNP) region rs7216389 tags the 3’ 
flanking region of ORMDL3 at 17q21; this is significantly associated with both asthmas 
and increased risk of glioma, reported as OR with 95% CI (1.10, 1.01-1.19).15 In a multi-
national case-control study that assessed social contacts and CNS tumor risk Andersen, 
et. al., found that children with at least four sick days per month in their first six years of 
life had a significantly increased risk of glioma, reported with 95% CI (OR=2.93, 1.57-
5.50).8 These results make sense in the context of increased CBT risk observed by 
Cantwell, et. al., in children born into families with at least three other children.11 
Summary 
 The current literature provides evidence that several risk factors may be 
associated with an increased risk for CBT, including parental occupational exposure to 
animals, lead, and some aromatic solvents; higher circulating vitamin D3 levels in 
neonates; high birth weight; being born into a larger family; being born to a mother with 
a history of miscarriage; maternal age; maternal genital herpes; maternal blood/immune 
disorders during pregnancy; being born with birth defects; having a genotype that 
predisposes one to asthma; and frequent infections in the first six years of life. Evidence, 
however, is most robust for the following risk factors: non-chromosomal birth defects, 
paternal exposure to non-benzene aromatic solvents, high fetal growth that may be 
related to circulating vitamin D3 levels, and maternal age over 35 years. 
METHODS 
Study Design and Data 
This cross-sectional study was approved by the institutional review board of the 
University of Kentucky on March 28, 2017. The Kentucky Cancer Registry (KCR) 
University of Kentucky  Khoury | 11 
supplied data on CBT cases diagnosed from January 1, 1995 through December 31, 2014. 
The KCR is Kentucky’s mandatory population-based central cancer registry and is part of 
the Markey Cancer Control Program’s integrated cancer control effort; the KCR has 
collected uniform data for all cancer cases among Kentucky residents since 1995.37 Data 
for this study were obtained from the KCR for all cases of retinoblastoma and CNS 
tumors in Kentucky for individuals aged 0 to 19 years from 1995 to 2014. The 
retinoblastoma dataset included tumors identified for three histological subtypes; the 
CNS tumor dataset included tumors for 56 histological subtypes. 
Spatial scan statistics were used to identify high-rate clusters of CBT incidence in 
Kentucky from 1995 to 2014. This technique was chosen because brain cancer is a rare 
event, and county-level incidence rates are thus highly unstable. Spatial scan statistics, 
unlike other common local cluster analysis options (e.g., local Moran’s I and Getis-Ord 
Gi*), enable a Poisson-based analysis based on case and population counts. Spatial scan 
statistics were implemented using SaTScan version 9.4.4.  
SaTScan is a free software that analyzes spatial, temporal, and space-time data 
using scan statistics. It was developed by Martin Kulldorff in association with 
Information Management Services Incorporated, with financial support from multiple 
divisions within the National Cancer Institute (NCI), the Alfred P. Sloan Foundation, the 
Centers for Disease Control and Prevention (CDC), the National Institute of Child Health 
and Development, and the National Institute of General Medical Sciences.38 
Several researchers have used spatial scan statistics to identify high-rate brain 
cancer clusters.39-41 Kulldorff, et. al., utilized spatial scan statistics to determine if rates of 
brain cancer were not greater than expected in the Los Alamos neighborhood of New 
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Mexico.39 Smith, et. al., used spatial scan statistics, in addition to other methods, to 
determine if there were geographical clusters of childhood astrocytoma cases in 
Sweden.40 Fang, et. al., used spatial scan statistics to investigate descriptive statistics that 
indicated geographical differences of brain cancer mortality in the U.S.41 
In a spatial scan statistic, circular or elliptical scan windows of varying sizes, are 
centered on the centroids of every region, and are generated across the study area to 
identify groups of contiguous regions that have significantly higher (or lower) rates of 
disease than expected. These scan windows represent potential clusters, and sizes vary 
continuously until the maximum population at risk is in the window. Windows in which 
disease rates are greater (or less) than regions outside of the scan window are identified 
as clusters. Space-time scan statistics are calculated using cylindrical scan windows, the 
heights of which correspond to time periods for potential clusters. A Monte Carlo 
simulation is used to determine p-values for scan statistics, comparing the calculated test 
statistic to statistics that were generated under the null hypothesis that disease clusters did 
not exist.38 Within clusters, p-values indicate the probability that disease rates are higher 
(or lower) than rates in the rest of the study area. 
Since a discrete Poisson distribution was used to model the probability of high-
rate clusters, we obtained population data from the CDC WONDER database Bridged-
Race Resident Population Estimates United States, State and County for the years 1990-
2015. CDC WONDER data, rather than KCR data, was used for the population 
denominator because population counts within specific demographic categories were 
necessary to conduct adjusted analysis. Although KCR data uses Census data to provide 
population estimates, these estimates are aggregated and are not provided by age, race, or 
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sex. The CDC WONDER data, which comprise population estimates for each county in 
Kentucky, were downloaded on April 17, 2017.42 We used the SaTScan software, along 
with the population data and the case data, to calculate outcome rates within each county 
and for each group defined by potential confounders (i.e., age, race, and sex).  
For the years 1990 through 2009, inter-censal estimates of the July 1 resident 
population were used; starting in 2010, July 1 post-censal estimates were used. Inter-
censal estimates are determined by taking into account two completed censuses and 
adjusting post-censal series of estimates for differences between census population counts 
and previously-calculated estimates; post-censal estimates are determined using measures 
of population change. For the years where inter-censal estimates were used, county-level 
data differs from state- and national-level data because rounding created some negative 
population counts that were changed to a value of zero.  
Variable Selection 
 We stratified the data by type of cancer. Thus, one case dataset included 
retinoblastoma cases (N=81) only, and another dataset included all other CNS tumor 
cases (N=1042). Variables available for analysis included year of diagnosis, county of 
residence at time of diagnosis, age at diagnosis, sex, and race (white or non-white). The 
geographical unit of analysis for this study was county of residence at time of diagnosis. 
A new age variable was created by categorizing age at diagnosis as either 0 to 4 years of 
5 to 19 years; these categories were chosen to maintain consistency with data previously 
presented at the Interim Joint Committee on Health Welfare.32 Among the cases of 
retinoblastoma, one individual’s race was “unknown”; there were 14 cases for whom race 
was “unknown” in the CNS tumor dataset. Rather than excluding these cases, “unknown” 
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race was changed to “white”, since the great majority of Kentucky’s population is white. 
According to the 2010 US Census, 81% of Kentucky’s population ages 0 to 19 years is 
“white”; this demographic was estimated as 79% in 2015.43  
Analysis was adjusted for age, sex, and race to adjust for population differences 
across regions of Kentucky. Population data, gathered for the years 1995 through 2014, 
therefore, were stratified by age (using the age categories described above), sex, and race. 
This created eight new demographic sub-groups, including white males aged 0 to 4 years, 
white males aged 5 to 19 years, white females aged 0 to 4 years, white females aged 5 to 
19 years, non-white males aged 0 to 4 years, non-white males aged 5 to 19 years, non-
white females aged 0 to 4 years, and non-white females aged 5 to 19 years. This data was 
collected for each county for each year during this time period.  
Statistical Analysis 
 The number of cases in each county is Poisson distributed because the dataset 
provides case count information, and CBT diagnoses occur independently. Therefore, the 
discrete Poisson model was used for SaTScan analysis. Under this model, it is expected 
that the number of diagnoses in each county is proportional to its population size. Since 
we adjusted for demographic variables, an expected number of cases was calculated 
(using SaTScan) for each of the eight demographic subgroups– combination of binary 
age, race, and sex categories – across the study period. The purpose of adjusted analysis 
was to account for effects of these covariates on retinoblastoma or CNS tumor incidence. 
As previously mentioned, population differences exist across the regions of Kentucky, 
and such factors may be related to development of CBT. 
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A preliminary and purely spatial analysis – using a circular scan window with a 
maximum 50% of the population at risk – was conducted first. Spatio-temporal analyses - 
using circular scan windows with maximums of 50% and 25% of the population at risk – 
were then conducted. After conducting these preliminary analyses, a second spatio-
temporal analysis was conducted – using an elliptical scan window with a maximum of 
25% of the population at risk – to characterize more specific temporal and spatial 
patterns. For the spatio-temporal analyses, time was aggregated to year of diagnosis. A 
significance level of 0.05 was used to determine if clusters had statistically significant 
higher rates of either retinoblastoma or CNS tumor compared to the rest of Kentucky. 
This analysis was conducted twice, once for retinoblastoma and once for CNS tumors. 
Additionally, an analysis was conducted combining the retinoblastoma and CNS tumor 
data to compare to results from the stratified analysis. 
RESULTS 
 Table 2.1 and 2.2 provide a summary of demographics for cases of retinoblastoma 
and CNS tumors, as well as the total populations within each demographic category in 
Kentucky from 1995 through 2014.42 Total population information is provided for 
comparison because case data was aggregated over this time period. Retinoblastoma 
disproportionately affects males (60.5% of cases compared to 51.3% males aged 0 to 19 
years in KY) and children aged 0 to 4 years (98.8% of cases compared to 24.3% of the 0-
to-4 year old population during this period). The majority of retinoblastoma cases 
diagnosed between the ages of zero and four years is consistent with an average age of 
three years reported in the literature.44 Additionally, the majority of retinoblastoma cases 
(90.1%) were white. Among cases of CNS tumor, 48.7% were male and 51.3% were 
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female. The majority of cases (73.6%) were between the ages of 5 and 19 years, and 
91.2% of cases were white.  
 Tables 3.1 and 3.2 provide a summary of the elliptical scan statistics that were 
calculated for cases of retinoblastoma and CNS tumors. None of the clusters identified in 
the retinoblastoma dataset were significant. One statistically significant cluster was 
identified in the CNS tumor dataset. The time frame for this cluster was January 1, 2007 
to December 31, 2014. The relative risk within the cluster was 1.87, with a p-value of less 
than 0.0001. This indicates that risk of developing a CNS tumor within these counties 
during this period was approximately 87% greater than in the rest of the state. 
 Figures 1.1 and 1.2 show the clusters identified using elliptical scan windows and 
setting the maximum population at risk to 25%. In these figures, the counties of 
Appalachia are shown in grey. Figure 1.1 shows four high-rate clusters of retinoblastoma, 
two of which lie in Appalachia; none of these clusters were statistically significant. 
Figure 1.2 shows three high-rate clusters of CNS tumors, two of which are statistically 
nonsignificant (indicated by black outlines). The statistically significant cluster has red 
outlines and encompasses 40 counties. Approximately half of this cluster lies across part 
of Appalachian Kentucky.45 
 Table 3.3 provides a summary of the analysis conducted for retinoblastoma and 
CNS tumor cases combined. Similar to CNS tumor cases, one large significant cluster 
(p=0.0004) was identified across the northern part of Appalachian Kentucky and the 
northern central part of Kentucky; the time frame for this cluster was also January 1, 
2007 through December 31, 2014 and included only four additional cases. Four other 
clusters were identified, all of which were non-significant. Clusters 2 and 3 were similar 
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in location to the non-significant clusters identified for CNS tumor, but had different time 
frames than clusters identified for either retinoblastoma or CNS tumor. Additional non-
significant clusters were identified in the north western part of Kentucky. The locations 
of these clusters are shown in Figure 1.3. 
DISCUSSION 
 The purpose of this study was to identify high-rate clusters of retinoblastomas or 
other CNS tumors in Kentucky between the years 1995 and 2014 for individuals aged 0 
to 19 years, after adjusting for basic demographic factors. No significant high-rate 
clusters of retinoblastoma were observed. One significant high-rate cluster was observed 
among those diagnosed with a CNS tumor, even after adjustment for race, sex, and age. 
This finding was somewhat consistent with preliminary analysis suggesting that age-
adjusted childhood cancer incidence rates in Appalachian Kentucky are higher than in the 
rest of the state.32 This cluster of high rates, however, extended into portions of Central 
and Northern Kentucky that are not generally considered Appalachia. 
Comparison with Other Studies 
Previous studies have indicated the utility of using spatial scan statistics to 
identify high-rate clusters of brain cancer incidence.39-41 Kulldorff, et. al., used the spatial 
scan statistic to confirm the findings of a public health review in New Mexico that excess 
brain cancer mortality was not significantly higher in the region surrounding a nuclear 
research facility in Los Alamos.39 Similarly, in this study we investigated findings from a 
previous study that claimed higher CBT incidence in one region of Kentucky. As this is a 
pilot study, however, additional studies will need to be conducted to investigate what 
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factors may be associated with increased diagnoses of CNS tumors in the cluster that was 
identified. 
Smith, et. al., conducted a population-based study of pediatric brain tumors in 
Sweden, and found that there were no statistically significant clusters (either spatial or 
temporal) found for cases of either astrocytoma or all cases of CNS tumor.40 Similarly, 
we found a significant spatio-temporal cluster for cases of CNS tumor. This study, 
however, included a broader age range (0 to 19 years versus 0 to 15 years) and had 
defined geographic boundaries throughout the entire study period (Sweden’s parishes 
have experienced minor geographic boundaries changes, so a geographically constant 
standard had to be used). The risk factors of these populations are likely also different, 
highlighting the need for geographical analyses of CBT incidence in different regions. 
Investigating previously published descriptive statistics on brain cancer mortality 
in the United States, Fang, et. al., used the spatial scan statistic to determine if high-rate 
geographical clusters existed in certain regions. In that study, significantly higher 
mortality was found among all adults in Southern west Kentucky and among men in of 
Western Kentucky and Tennessee, in addition to higher rates in other parts of the U.S.41 
Although this study used a similar methodology, it focused on the United States as a 
whole rather than Kentucky. Additionally, a cluster of individuals under age 20 years in 
Western Kentucky and Tennessee were non-significant.41 This may be due to less 
mortality among children compared to adults, but also to smaller case counts. The only 
cluster we identified in this region of Kentucky was for retinoblastoma – which has a 
five-year survival rate of 95% – and was also non-significant.7  
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Possible Risk Factors for CNS Tumor 
The present study identified a region of Kentucky with greater than expected 
diagnoses of CNS tumors in children; currently, evidence is inconsistent about risk 
factors. The Kentucky Birth Surveillance Registry (KBSR), which provides birth 
statistics for Kentucky from 2005 through 2014, produced a map (Figure 2.1) displaying 
rates of major non-chromosomal birth defects (including neural tube defects) by region.46 
The statistically significant cluster shown in Figure 2.2 encompasses two of the regions 
with the highest rates of birth defects, but also includes regions with lower rates. It is not 
possible, however, to conclude there is an association between birth defects and the 
identified cluster because it is not possible to compare rates at different scales. There is 
limited data available for infant birth weight and maternal age by either county or region 
in Kentucky, and recent requests for data from the Kentucky Cabinet for Health and 
Family Services have not been successful. In future analysis, it would be beneficial to 
link vital statistics records to cases in the KCR dataset, to determine if rates of CNS 
tumor are greater in regions with LGA infants and/or mothers age 35 years and older. 
Data is not available regarding paternal occupational exposures to non-benzene aromatic 
solvents. 
Strengths and Limitations 
 The main strength of this study was the completeness of the datasets from the 
KCR and the CDC WONDER database. KCR data has been uniformly collected since the 
registry was mandated in 1995, providing twenty years of information on case 
demographics and county of residence. Therefore, it was possible to compare data over 
the study period to identify where clusters existed within the study. This is also beneficial 
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for determining possible causes of increased CBT rates within clusters. The CDC 
WONDER database uses census information to estimate population counts, and has a 
defined method for calculating population in non-census years. Therefore, it was possible 
to create defined demographic subgroups to conduct adjusted analysis. 
 This study had multiple limitations. Kentucky consists of 120 counties, some 
having considerably smaller populations than others and would have expected rates of 
retinoblastoma or CNS tumor close to zero. Compared to counties with larger 
populations, this could increase the rate of diagnosis in a county or region in some years 
and increase the spatial scan statistic within a cluster, influencing where high-rate clusters 
were identified. Adjusting for age, race, and sex, however, reduced these effects. Small 
populations also influence the maximum population at risk, as more counties would have 
to be included in a cluster to meet the pre-determined window size. To minimize the 
radius of scan windows and ensure that only counties with truly higher rates of diagnoses 
were included in clusters, the maximum population at risk was defined as 25% rather 
than 50%.  
Small case counts exist because cancer, especially retinoblastoma, is a rare event. 
Regions in which retinoblastoma cases were diagnosed, therefore, sometimes appear to 
have high incidence rates when any diagnoses were made. Analyzing data over a long 
time period increases case counts, and may lead to the identification of significant 
clusters. The earlier presentation to the Interim Joint Committee on Health and Welfare – 
that indicated high incidence rates of CNS tumors (significant) and retinoblastoma (non-
significant) – analyzed data from diagnoses made between 1999 and 2013. Therefore, we 
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looked at cases from 1995 through 2014. No significant clusters of retinoblastoma were 
identified however, so future analysis would benefit from additional years of data. 
Race was “unknown” and changed to “white” for fifteen cases. This may have 
influenced analysis because of the small case counts in each year of the study period. 
Although race was adjusted for in analysis, changing race in the dataset could lead to an 
underestimation of retinoblastoma or CNS tumor incidence among those who are non-
white.  
Future Directions 
 In the present study, it was not possible to assess the relationship between 
possible risk factors and the high-risk CNS tumor cluster that was identified because 
necessary data was not available. Following this exploratory analysis, future plans are to 
explore what factors are contributing to increased rates of CNS tumor in the cluster 
detected by the spatial scan statistic. Since it is not possible, with data from the KBSR, to 
conclude that birth defects are greater in the cluster region than in the rest of the state, it 
would be worthwhile to obtain birth defect data to conduct further analysis. Additionally, 
data for birth weight and maternal age need to be examined to compare CNS tumor rates 
in this region to the rest of the state after adjusting for those factors. This could be done 
by linking birth records to cases in the KCR dataset. To further investigate the impact of 
paternal occupational exposure to solvents, a case-control study could be conducted 
within the region of the statistically significant cluster. 
CONCLUSIONS 
 This preliminary study identified one statistically significant high-rate cluster for 
cases of CNS tumor for individuals aged 0 to 19 years in Kentucky between 1995 and 
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2014, but did not identify significant high-rate clusters of retinoblastoma. This cluster 
was across the northern part of Appalachian Kentucky and northern and central parts of 
the state. While this somewhat corresponds to previous findings, it is important to note 
that this cluster was not confined to Appalachia. Because there are currently not data 
available to investigate why this cluster exists, future aims as a result of findings from 
this pilot study are to identify possible risk factors that may be causing this increase. 
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Appendix 
Table 1.1: Age-adjusted incidence rates of Pediatric CNS tumor and retinoblastoma 
cases per 1,000,000, Ages 0 to 19 Years, 2010 through 2014 
 
Appalachian KY State of Kentucky United States 
CNS tumors 45.7 (35.4-58.0) 40.5 (35.4-46.1) 32.2 (31.6-32.7) 
Retinoblastoma 6.8 (3.3-12.5)* 4.0 (2.5-6.0) 3.3 (3.1-3.4) 
Table 1.1 displays age-adjusted incidence rates per 1,000,000 of CNS tumor and 
retinoblastoma from 2010 through 2014, for individuals aged 0 to 19 years.33,34 Shown in 
parentheses are 95% confidence intervals. Rates are significantly different when 
confidence intervals do not overlap. An asterisk (*) indicates that rates are unstable do to 
case counts under 15.  
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Table 2.1: Retinoblastoma Case Demographics, Kentucky, 1995 through 2014 
 
Retinoblastoma 
Cases (N=81) 
n (%) 
Kentucky 
(N=22,459,624) 
n (%) 
Race   
White 73 (90.1%) 19,818,448 (88.2%) 
Non-White 8 (9.9%) 2,641,176 (11.8%) 
Sex   
Male 49 (60.5%) 11,525,495 (51.3%) 
Female 32 (39.5%) 10,934,129 (48.7%) 
Age   
0-4 Years 80 (98.8%) 5,447,740 (24.3%) 
5-19 Years 1 (1.2%) 17,011,884 (75.7%) 
 
Table 2.1 displays the demographics of retinoblastoma cases, in addition to demographics 
for all individuals aged 0 to 19 years in Kentucky from 1995 through 2014. 
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Table 2.2: CNS Tumor Case Demographics, Kentucky, 1995 through 2014 
 CNS tumor 
(N=1042) 
n (%) 
Kentucky 
(N=22,459,624) 
n (%) 
Race   
White 950 (91.2%) 19,818,448 (88.2%) 
Non-White 92 (8.8%) 2,641,176 (11.8%) 
Sex   
Male 507 (48.7%) 11,525,495 (51.3%) 
Female 535 (51.3%) 10,934,129 (48.7%) 
Age   
0-4 Years 275 (26.4%) 5,447,740 (24.3%) 
5-19 Years 767 (73.6%) 17,011,884 (75.7%) 
 
Table 2.2 displays the demographics of CNS tumor cases, in addition to demographics 
for all individuals aged 0 to 19 years in Kentucky from 1995 through 2014. 
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Table 3.1: Retinoblastoma Spatial Scan Statistic Summary Using Elliptical Scan 
Window with 25% Maximum Population at Risk, Kentucky, 1995 through 2014 
 
Time 
Frame 
Number 
of Cases 
Expected 
Cases 
Observed/ 
Expected 
Relative 
Risk 
Test 
Statistic 
p-
value 
Cluster 
1 
1/1/2010 to 
12/31/2011 
8 0.92 8.68 9.52 9.93 0.171 
Cluster 
2 
1/1/1999 to 
12/31/2000 
2 0.028 71.59 73.38 6.59 0.928 
Cluster 
3 
1/1/2013 to 
12/31/2013 
4 0.24 16.54 17.35 6.54 0.935 
Cluster 
4 
1/1/2009 to 
12/31/2009 
2 0.039 50.71 51.97 5.80 0.983 
Table 3.1 displays summary values from calculating spatial scan statistics for the 
retinoblastoma dataset. There were no statistically significant high-rate clusters in this 
dataset. 
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Table 3.2: CNS Tumor Spatial Scan Statistic Summary Using Elliptical Scan 
Window with 25% Maximum Population at Risk, Kentucky, 1995 through 2014 
 Time Frame 
Number 
of Cases 
Expected 
Cases 
Observed/ 
Expected 
Relative 
Risk 
Test 
Statistic 
p-value 
Cluster 
1 
1/1/2007 to 
12/31/2014 
179 104.04 1.72 1.87 20.19 >0.0001 
Cluster 
2 
1/1/2009 to 
12/31/2009 
6 0.56 10.68 10.73 8.78 0.551 
Cluster 
3 
1/1/2004 to 
12/31/2013 
64 34.86 1.84 1.89 7.58 0.878 
Table 3.2 displays summary values from calculating spatial scan statistics for the CNS 
tumor dataset. There was one statistically significant high-rate cluster (Cluster 1) in this 
dataset.  
  
University of Kentucky  Khoury | 31 
Table 3.3: Retinoblastoma and CNS Tumor Combined Analysis Spatial Scan 
Statistic Summary Using Elliptical Scan Window with 25% Maximum Population 
at Risk, Kentucky, 1995 through 2014 
 
Table 3.3 displays summary values from calculating spatial scan statistics for the 
Retinoblastoma and CNS tumor datasets. There was one statistically significant high-rate 
cluster (Cluster 1) in this dataset.  
  
 
Time Frame Number 
of Cases 
Expected 
Cases 
Observed/ 
Expected 
Relative 
Risk 
Test 
Statistic 
p-value 
Cluster 
1 
1/1/2007 to 
12/31/2014 
183 110.60 1.65 1.78 17.93 0.0004 
Cluster 
2 
1/1/2005 to 
12/31/2014 
30 11.05 2.71 2.76 9.67 0.353 
Cluster 
3 
1/1/2006 to 
12/31/2013 
153 107.36 1.43 1.49 7.16 0.939 
Cluster 
4 
1/1/2009 to 
12/31/2010 
10 2.64 3.79 3.81 5.98 0.999 
Cluster 
5 
1/1/2004 to 
12/31/2013 
26 11.97 2.17 2.20 5.87 0.999 
University of Kentucky  Khoury | 32 
Figure 1.1: High-Rate Clusters of Retinoblastoma Identified by Spatial Scan 
Statistics 
This map displays the four high-rate clusters of retinoblastoma diagnoses identified by 
spatial scan statistics, none of which are statistically significant.  
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Figure 1.2: High-Rate Clusters of CNS Tumor Identified by Spatial Scan Statistics 
Figure 1.2 displays the three high-rate clusters of CNS tumor diagnoses identified by 
spatial scan statistics, only one of which is statistically significant (outlined in red, with 
counties labeled). 
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Figure 1.2: High-Rate Clusters of Retinoblastoma and CNS Tumor Identified by 
Spatial Scan Statistics 
Figure 1.3 displays the five high-rate clusters of Retinoblastoma and CNS tumor 
diagnoses identified by spatial scan statistics, only one of which is statistically significant 
(outlined in red, with counties labeled). 
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Figure 2.1: Rate of Selected Major Birth Defects by ADD, per 10,000 Live Births, 
Kentucky, 2005 through 2014 
This figure was prepared by Emily Ferrell, MPH CPH, from the Division of Maternal and 
Child Health at the Kentucky Department for Public Health, and was originally presented 
in the 2005-2014 Kentucky Birth Surveillance Report (KBSR), which was released 
August 2016.46 Data used to create this figure was retrieved from the Kentucky Birth 
Surveillance Registry, Kentucky Live Birth Certificates, and Kentucky Stillbirth 
certificates. Selected major birth defects included critical congenital heart defects, 
orofacial clefts, down syndrome, neural tube defects, diaphragmatic hernia, and 
gastroschisis. Rates shown are per 10,000 live births. 
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